Carboxylate derivatives of tributyltin (IV) complexes as anticancer and antileishmanial agents.

Antileishmanial activity Tributyltin (IV) compounds demonstrated highly significant ( p < 0.05) antileishmanial activity with >90% lethality and very low LC50s ranging from 0.954 ± 0.158 μg/mL to 0.078 ± 0.002 μg/mL (Table 3 ).

also in 132,142 other papers